Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fluoxetine and sertraline based multitarget inhibitors of cholinesterases and monoamine oxidase-A/B for the treatment of Alzheimer's disease: Synthesis, pharmacology and molecular modeling studies
Muhammad Shahid Nadeem, Jalaluddin Azam Khan, Umer Rashid
International Journal of Biological Macromolecules (2021) Vol. 193, pp. 19-26
Closed Access | Times Cited: 15

Showing 15 citing articles:

Exploitation of the multitarget role of new ferulic and gallic acid derivatives in oxidative stress-related Alzheimer's disease therapies: design, synthesis and bioevaluation
Fahad Hussain, Ayesha Tahir, Muhammad Saeed Jan, et al.
RSC Advances (2024) Vol. 14, Iss. 15, pp. 10304-10321
Open Access | Times Cited: 8
Design, Synthesis, and Bioevaluation of Indole Core Containing 2-Arylidine Derivatives of Thiazolopyrimidine as Multitarget Inhibitors of Cholinesterases and Monoamine Oxidase A/B for the Treatment of Alzheimer Disease
Muhammad Shahid Nadeem, Jalaluddin Azam Khan, Imran Kazmi, et al.
ACS Omega (2022) Vol. 7, Iss. 11, pp. 9369-9379
Open Access | Times Cited: 36
Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer’s disease
Da-Jiang Zou, Renzheng Liu, Yangjing Lv, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 19
Evaluation of pyrimidine/pyrrolidine-sertraline based hybrids as multitarget anti-Alzheimer agents: In-vitro, in-vivo, and computational studies
Muhammad Aamir Javed, Muhammad Saeed Jan, Abdullah M. Shbeer, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114239-114239
Open Access | Times Cited: 18
Synthesis, Pharmacological Evaluation, and Molecular Modeling of Phthalimide Derivatives as Monoamine Oxidase and Cholinesterase Dual Inhibitors
Nabiha Abdullah, Fahad Hussain, Naseem Ullah, et al.
ACS Omega (2025)
Open Access
Diclofenac derivatives as concomitant inhibitors of cholinesterase, monoamine oxidase, cyclooxygenase-2 and 5-lipoxygenase for the treatment of Alzheimer's disease: synthesis, pharmacology, toxicity and docking studies
Muhammad Aamir Javed, Saba Bibi, Muhammad Saeed Jan, et al.
RSC Advances (2022) Vol. 12, Iss. 35, pp. 22503-22517
Open Access | Times Cited: 26
In-Vitro, In-Vivo, Molecular Docking and ADMET Studies of 2-Substituted 3,7-Dihydroxy-4H-chromen-4-one for Oxidative Stress, Inflammation and Alzheimer’s Disease
Mater H. Mahnashi, Mohammed Abdulrahman Alshahrani, Mohammed H. Nahari, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1055-1055
Open Access | Times Cited: 23
Dual-Target Inhibitors Based on Acetylcholinesterase: Novel Agents for Alzheimer's Disease
Xingyi Zhao, Qiaoguan Hu, Xiaoqian Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116810-116810
Closed Access | Times Cited: 4
Synthesis, characterization, anticancer, anti-inflammatory activities, and docking studies of 3,5-disubstituted thiadiazine-2-thiones
Haleema Ali, Rasool Khan, Xiandao Pan, et al.
Green Processing and Synthesis (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Multi-target QSAR modeling for the identification of novel inhibitors against Alzheimer's disease
Vinay Kumar, Achintya Saha, Kunal Roy
Chemometrics and Intelligent Laboratory Systems (2022) Vol. 233, pp. 104734-104734
Closed Access | Times Cited: 7
Design, synthesis, crystal structures, computational studies, in vitro and in silico monoamine oxidase-A&B inhibitory activity of two novel S-benzyl dithiocarbamates
Bilal Ahmad Khan, Syeda Shamila Hamdani, Muhammad Naeem Ahmed, et al.
Journal of Molecular Structure (2022) Vol. 1265, pp. 133317-133317
Closed Access | Times Cited: 6
Design, synthesis, in-vitro, in-vivo and ex-vivo pharmacology of thiazolidine-2,4-dione derivatives as selective and reversible monoamine oxidase-B inhibitors
Ridha Jadoon, Muhammad Aamir Javed, Muhammad Saeed Jan, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 76, pp. 128994-128994
Closed Access | Times Cited: 6
Recent Progress in the Treatment Strategies for Alzheimer’s Disease
Vinay Kumar, Kunal Roy
Neuromethods (2023), pp. 3-47
Closed Access | Times Cited: 2
Design, synthesis, antiproliferative activity, estrogen receptors binding affinity of C-3 pregnenolone-dihydropyrimidine derivatives for the treatment of breast cancer
Bandar A. Alyami, Iqra Ejaz, Mater H. Mahnashi, et al.
Steroids (2022) Vol. 185, pp. 109059-109059
Closed Access | Times Cited: 3
In vitro anti-inflammatory, antidiabetic, antibacterial, and in silico studies of Ferruginan A isolated from Olea ferruginea Royle (Oleaceae)
Abdur Rauf, Bassam Oudh Al Johny, Umer Rashid, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 12, pp. 101868-101868
Open Access | Times Cited: 1
Page 1

Scroll to top